Recent scientific developments in medicine have the potential to cure or fundamentally modify previously incurable or poorly treated diseases and conditions, relieving the suffering of patients and ...

As America’s healthcare system continues to evolve, it is critical that our perception of care and its value to patients evolves with it. In the past, value assessments have marginalized patients’ ...

The Institute for Clinical and Economic Review, also known as drug-pricing watchdog ICER, has partnered with medical data firm Aetion to help analyze the real-world performance of different treatments ...

Two of the panelists appearing during the Virtual ISPOR 2020 meeting preview what's needed in improving value assessment: Lou Garrison, PhD, of the University of Washington, and Leah Howard, JD, of ...